Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis
Yanli Li, Xinmei Kang, Zhuowei Zhou, et al.
Molecular Therapy (2022) Vol. 30, Iss. 12, pp. 3714-3728
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Histone demethylases in the regulation of immunity and inflammation
Lihua Qu, Tong Yin, Yijin Zhao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 28
PXR Activation Relieves Deoxynivalenol‐Induced Liver Oxidative Stress Via Malat1 LncRNA m6A Demethylation
Yue Feng, Jiakun Shen, Zishen Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 12
Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases
Faiz Ali Khan, Bernard Nsengimana, Usman Ayub Awan, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 8
DNA 5mC and RNA m6A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression
Yue Feng, Shihui Guo, Yulan Zhao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1211-1220
Closed Access | Times Cited: 19
Gastric cancer-derived LBP promotes liver metastasis by driving intrahepatic fibrotic pre-metastatic niche formation
Li Xie, Shengkui Qiu, Lu Chen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
STUB1 is acetylated by KAT5 and alleviates myocardial ischemia-reperfusion injury through LATS2-YAP-β-catenin axis
Can Liu, Zhongxuan Gui, Cheng An, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs
Xiangfei Huang, Zilu Yu, Juan Tian, et al.
Briefings in Functional Genomics (2025) Vol. 24
Closed Access
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
Xiaoyong Xue, Runping Liu, Yajie Cai, et al.
Journal of Hepatology (2025)
Closed Access
Quercetin attenuated necroptosis and apoptosis caused by LPS-induced mitochondrial function dysfunction through the METTL3-mediated PTEN m6A methylation/PI3K/AKT signaling in broiler livers
Xia Yu, Yidan Wang, Kai Chen, et al.
Phytomedicine (2025) Vol. 139, pp. 156551-156551
Closed Access
Novel Epitranscriptomic and Epigenetic Therapeutic Strategies and Targets for Ferroptosis in Liver Fibrosis
Minghui Li, Yang Yang, Qi-Qi Dong, et al.
European Journal of Pharmacology (2025) Vol. 996, pp. 177344-177344
Closed Access
RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 4
N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1
Junfeng Wang, Min Du, Lingdu Meng, et al.
Hepatology Communications (2023) Vol. 7, Iss. 1, pp. e0004-e0004
Open Access | Times Cited: 9
LATS2 degradation promoted fibrosis damage and rescued by vitamin K3 in lupus nephritis
Chen Cheng, Hao Yang, Chan Yang, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 3
Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 7
N6-methyladenosine-dependent signaling in colorectal cancer: Functions and clinical potential
Shaojun Liu, Min Liu, Yuxuan Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104360-104360
Open Access | Times Cited: 2
Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma
Xuan Zha, Zewei Gao, Min Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116966-116966
Open Access | Times Cited: 2
Epitranscriptomic regulation of lipid oxidation and liver fibrosis via ENPP1 mRNA m6A modification
Feng Sun, Juan Wang, Yang Yang, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Tumor-derived CCL15 regulates RNA m6A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth
Chaomin Wang, Dong Dong, Na Zhao, et al.
Cancer Letters (2024) Vol. 611, pp. 217420-217420
Closed Access | Times Cited: 2
Jiawei Taohe Chengqi decoction inhibition of the notch signal pathway affects macrophage reprogramming to inhibit HSCs activation for the treatment of hepatic fibrosis
Chang Shao, Huihui Xu, Xiguang Sun, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117486-117486
Closed Access | Times Cited: 6
THE ROLE OF N6-METHYLADENOSINE METHYLTRANSFERASE RBM15 IN NONALCOHOLIC FATTY LIVER DISEASE
Shiqing Li, Shengyi Lian, Wei Cheng, et al.
Shock (2023) Vol. 61, Iss. 2, pp. 311-321
Closed Access | Times Cited: 5
METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2–dependent mechanism
Xiaoxue Hou, Yuwen Li, Jiali Song, et al.
Hepatology Communications (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 4
FTO-mediated m<sup>6</sup>A demethylation of ULK1 mRNA promotes autophagy and activation of hepatic stellate cells in liver fibrosis
Tingjuan Huang, Chunhong Zhang, Junjie Ren, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top